These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 29685123)

  • 1. The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):454. PubMed ID: 29685123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):389. PubMed ID: 29621994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pursuing germline genome sequencing to reduce illness uncertainty may involve additional uncertainties for cancer patients: A mixed-methods study.
    Bartley N; Best M; Butow P
    J Genet Couns; 2021 Aug; 30(4):1143-1155. PubMed ID: 33786948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer patients' views and understanding of genome sequencing: a qualitative study.
    Bartley N; Best M; Jacobs C; Juraskova I; Newson AJ; Savard J; Meiser B; Ballinger ML; Thomas DM; Biesecker B; Butow P
    J Med Genet; 2020 Oct; 57(10):671-676. PubMed ID: 31980566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results.
    Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Best MC;
    Eur J Med Genet; 2022 Jun; 65(6):104516. PubMed ID: 35487418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speaking genomics to parents offered germline testing for cancer predisposition: Use of a 2-visit consent model.
    Johnson LM; Sykes AD; Lu Z; Valdez JM; Gattuso J; Gerhardt E; Hamilton KV; Harrison LW; Hines-Dowell SJ; Jurbergs N; McGee RB; Nuccio R; Ouma AA; Pritchard M; Quinn EA; Baker JN; Mandrell BN; Nichols KE
    Cancer; 2019 Jul; 125(14):2455-2464. PubMed ID: 30901077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a comprehensive prospective cohort study of trio-based whole-genome sequencing for underlying cancer predisposition in paediatric and adolescent patients newly diagnosed with cancer: the PREDICT study.
    Fuentes Bolanos NA; Padhye B; Daley M; Hunter J; Hetherington K; Warby M; Courtney E; Kirk J; Josephi-Taylor S; Chen Y; Alvaro F; Barlow-Stewart K; Wong-Erasmus M; Barahona P; Ajuyah P; Altekoester AK; Tyrrell VJ; Lau LMS; Wakefield C; Sylvester D; Tucker K; Pinese M; Dalla Pozza L; O'Brien TA
    BMJ Open; 2023 May; 13(5):e070082. PubMed ID: 37253493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor genome analysis includes germline genome: are we ready for surprises?
    Catenacci DV; Amico AL; Nielsen SM; Geynisman DM; Rambo B; Carey GB; Gulden C; Fackenthal J; Marsh RD; Kindler HL; Olopade OI
    Int J Cancer; 2015 Apr; 136(7):1559-67. PubMed ID: 25123297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mainstreaming informed consent for genomic sequencing: A call for action.
    Bunnik EM; Dondorp WJ; Bredenoord AL; de Wert G; Cornel MC
    Eur J Cancer; 2021 May; 148():405-410. PubMed ID: 33784533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer patient knowledge about and behavioral intentions after germline genome sequencing.
    Napier CE; Davies G; Butow PN; Schlub TE; Best MC; Bartley N; Juraskova I; Meiser B; Tucker KM; Biesecker BB; Thomas DM; Ballinger ML;
    Patient Educ Couns; 2022 Mar; 105(3):707-718. PubMed ID: 34247865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who should access germline genome sequencing? A mixed methods study of patient views.
    Best MC; Butow P; Jacobs C; Savard J; Biesecker B; Ballinger ML; Bartley N; Davies G; Napier CE; Smit AK; Thomas DM; Newson AJ;
    Clin Genet; 2020 Feb; 97(2):329-337. PubMed ID: 31674008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australians' perspectives on support around use of personal genomic testing: Findings from the Genioz study.
    Metcalfe SA; Hickerton C; Savard J; Stackpoole E; Tytherleigh R; Tutty E; Terrill B; Turbitt E; Gray K; Middleton A; Wilson B; Newson AJ; Gaff C
    Eur J Med Genet; 2019 May; 62(5):290-299. PubMed ID: 30439534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study.
    Butow P; Davies G; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub T; Thomas DM; Goldstein D; Best MC;
    J Genet Couns; 2022 Feb; 31(1):96-108. PubMed ID: 34218500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol.
    Lewis C; Buchanan J; Clarke A; Clement E; Friedrich B; Hastings-Ward J; Hill M; Horn R; Lucassen AM; Patch C; Pickard A; Roberts L; Sanderson SC; Wynn SL; Vindrola-Padros C; Lakhanpaul M
    NIHR Open Res; 2021; 1():23. PubMed ID: 35098132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting.
    Best MC; Butow P; Savard J; Jacobs C; Bartley N; Davies G; Napier CE; Ballinger ML; Thomas DM; Biesecker B; Tucker KM; Juraskova I; Meiser B; Schlub T; Newson AJ
    Eur J Hum Genet; 2022 Aug; 30(8):930-937. PubMed ID: 35277654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; van Tintelen JP; Smets EMA; Christiaans I
    BMJ Open; 2019 Jul; 9(7):e025660. PubMed ID: 31289060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical frameworks for obtaining informed consent in tumour profiling: an evidence-based case for Singapore.
    Bylstra Y; Lysaght T; Thrivikraman J; Watson S; Tan P
    Hum Genomics; 2017 Dec; 11(1):31. PubMed ID: 29221462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
    Johnson LM; Valdez JM; Quinn EA; Sykes AD; McGee RB; Nuccio R; Hines-Dowell SJ; Baker JN; Kesserwan C; Nichols KE; Mandrell BN
    Cancer; 2017 Jun; 123(12):2352-2359. PubMed ID: 28192596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical providers' experiences with returning results from genomic sequencing: an interview study.
    Wynn J; Lewis K; Amendola LM; Bernhardt BA; Biswas S; Joshi M; McMullen C; Scollon S
    BMC Med Genomics; 2018 May; 11(1):45. PubMed ID: 29739461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.